Zishenpingchan granules for the treatment of Parkinson’s disease: a randomized, double-blind, placebo-controlled clinical trial
Levodopa preparations remain the preferred drug for Parkinson’s disease. However, long-term use of levodopa may lead to a series of motor complications. Previous studies have shown that the combination of levodopa and Zishenpingchan granules (consisting of Radix Rehmanniae preparata, Lycium barbarum...
Main Authors: | Qing Ye, Xiao-Lei Yuan, Can-Xing Yuan, Hong-Zhi Zhang, Xu-Ming Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2018;volume=13;issue=7;spage=1269;epage=1275;aulast=Ye |
Similar Items
-
Anti-apoptotic effect of Shudipingchan granule in the substantia nigra of rat models of Parkinson′s disease
by: Qing Ye, et al.
Published: (2016-01-01) -
Neuroprotective effect of Cerebralcare Granule after cerebral ischemia/reperfusion injury
by: Xiao-xiao Zhang, et al.
Published: (2016-01-01) -
Synaptic aging disrupts synaptic morphology and function in cerebellar Purkinje cells
by: Wen-Juan Fan, et al.
Published: (2018-01-01) -
Various changes in cryopreserved acellular nerve allografts at −80°C
by: Yan-Yan Huang, et al.
Published: (2018-01-01) -
Short-term observations of the regenerative potential of injured proximal sensory nerves crossed with distal motor nerves
by: Xiu-xiu Zhang, et al.
Published: (2017-01-01)